✦ LIBER ✦

A light in multidrug resistance: Photodynamic treatment of multidrug-resistant tumors

✍ Scribed by Márcia Alves Marques Capella; Luiz Sabbatini Capella

Publisher: BioMed Central
Year: 2003
Tongue: English
Weight: 914 KB
Volume: 10
Category: Article
ISSN: 1021-7770
DOI: 10.1007/bf02256427

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toremifene concentration and multidrug r

Toremifene concentration and multidrug resistance in lung tumors

✍ K. Liippo; Juha Ellmén; Esko Vänttinen; Markku Anttila 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 145 KB

Visualization of multidrug resistance in

Visualization of multidrug resistance in vivo

✍ N. H. Hendrikse; E. J. F. Franssen; W. T. A. van der Graaf; W. Vaalburg; E. G. E 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 101 KB

Diagnostics of multidrug resistance in c

Diagnostics of multidrug resistance in cancer

✍ SzakÁCs Gergely; Jakab Katalin; Antal Ferenc; Sarkadi Balázs 📂 Article 📅 1998 🏛 Springer Netherlands 🌐 English ⚖ 856 KB

Activity of the pyrazoloacridines agains

Activity of the pyrazoloacridines against multidrug-resistant tumor cells

✍ Judith Sebolt; Martha Havlick; Katherine Hamelehle; James Nelson; Wilbur Leopold 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 608 KB

ChemInform Abstract: Mechanism of Multid

ChemInform Abstract: Mechanism of Multidrug Resistant Tumors and Chemotherapeutic Approaches Against the Resistant Tumors

✍ T. TSURUO 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

Bispecific antibodies reactive with the

Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells

✍ J. van Dijk; T. Tsuruo; D. M. Segal; R. L. H. Bolhuis; R. Colognola; R. J. van d 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

## We describe the lysis of multidrug-resistant (MDR) tumor cells by various lymphocytic effector cells, retargeted with bispecific antibodies (heteroconjugates). The Ab -heteroconjugate used was prepared by chemically cross-linking the OKT3 monoclonal antibody (MAb) reactive with CD3 antigen on T